Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy

Grants

Funding Acknowledgements

This study was supported by an investigator-initiated grant from EISAI Australia Pty Limited. Eisai was not involved in the study design, the collection, analysis, and interpretation of the data gathered, the writing of the report, or the decision to submit the article for publication.